secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2024-12-27T23:59:59+00:00
Accession:  0001193125-24-285936
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech receives Nasdaq bid price deficiency notice; stock at risk of delisting
--------------------------------------------------------------------------------

- Nasdaq notice on Dec 26, 2024: common stock bid price below $1.00 for 30 consecutive days.
- Company has 180 days, until June 24, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
- Failure to comply could lead to delisting; may qualify for additional 180-day period if transferred to Nasdaq Capital Market.
- No immediate effect on listing; trading continues on Nasdaq Global Select Market pending compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524285936/0001193125-24-285936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524285936/d903966d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-285936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer